Tscan Therapeutics Inc

Tscan Therapeutics Inc

TCRX

Get informed when a big investor buys or sells

+ Follow
Market Cap$48.63M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Tscan Therapeutics IncTscan Therapeutics Inc-0.8--171%-1.3
$-1.58

Current Fair Value

304.4% downside

Overvalued by 304.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$48.63 Million
Enterprise Value$39.95 Million
Dividend Yield$- (-)
Earnings per Share$-1
Beta1.04
Outstanding Shares129,913,376

Return

Return on Equity-170.55%ROE
Return on Assets-68.66%
Return on Invested Capital-84.76%

Valuation & Multiples

P/E Ratio-0.83P/E Ratio
PEG4.65PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue8.68
Enterprise Value to EBIT-0.34
Enterprise Value to Net Income-1
Total Debt to Enterprise2.29
Debt to Equity1.33Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 12, 2026
EPS Estimate
$-0.25
Average shareholder expectation
Revenue Estimate
$1.88 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 19, 2026
EPS Estimate
$-0.26
Average shareholder expectation
Revenue Estimate
$1.88 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %24.99%▲ 1.36%
Total Invested$32.78M▲ 6.81%
Investors Holding58▼ 2.00%

ESG Score

No data

About Tscan Therapeutics Inc

61 employees